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We have investigated the IFN-mediated inhibition of human parainfluenza virus-3 (HPIV-3) replication in cultured human
A549 cells. IFN-a inhibited the virus yield significantly with concomitant reduction of viral RNA accumulation by more than
90%. Further studies indicated that the inhibitory action of IFN was at the level of primary transcription of HPIV3 replication.
Since the IFN-inducible protein, MxA, has been shown to inhibit virus replication in several RNA viruses, we examined the
role of MxA in HPIV-3 replication using a stably transfected human glioblastoma cell line expressing MxA. In these cells
HPIV-3 replication was decreased by more than 100-fold depending on the virus dosage used with concomitant inhibition
of viral RNA synthesis by about 80%. However, the viral primary transcription was not affected in this MxA-producing cell
line. In contrast, in the parental cell line IFN-mediated inhibition occurred at the primary transcription step of HPIV-3
replication. These data suggest that, in addition to MxA, other IFN-inducible proteins are involved in the anti-HPIV-3 effect
of IFN in both the cell lines used. q 1996 Academic Press, Inc.
INTRODUCTION replication of EMC virus (Meurs et al., 1992). (c) Mx pro-
teins (Pavlovic and Staeheli, 1991); IFN induces specific
Interferons (IFNs) are a heterogeneous family of pro-
proteins in mouse (Mx1) (Lindenmann, 1962) and in hu-
teins with antiviral activity (Kerr and Stark, 1992; McNair
mans (MxA) (Aebi et al., 1989; Horisberger et al., 1990)
and Kerr, 1992). They act via binding to species-specific
which inhibit virus replication. In human, MxA protein iscell surface receptors and by induction of intracellular
found predominantly in the cytoplasm and shown to beproteins (Sen and Lengyel, 1992). The antiviral effect of
able to inhibit replication of influenza virus (Pavlovic etIFN has been studied extensively and in some viral sys-
al., 1990), vesicular stomatitis virus (VSV) (Pavlovic et al.,tems the precise IFN-mediated inhibitory pathways have
1990), and measles virus (Schnorr et al., 1993) but failedbeen delineated (Staeheli, 1990; Samuel, 1991; Landolfo
to confer resistance to picornaviruses (Pavlovic et al.,et al., 1995). At the present time, three identifiable path-
1990). Although these three IFN-inducible pathways ac-ways have been implicated in IFN-mediated inhibition of
count for the inhibition of several RNA viruses, the mech-RNA viruses: (a) 2*-5*A (5*-phosphorylated, 2* to 5* linked
anisms for the inhibition of many other RNA viruses in-oligoadenylate) synthetase/RNase L pathway in which
cluding HPIV-3 by IFN still remain unknown (Staeheli,double-stranded RNA (dsRNA, an intermediate product
1990).of RNA virus replication) mediates synthesis of 2*-5*A by
HPIVs are second only to respiratory syncytial virusthe activation of 2*-5*A synthetase. The 2*-5*A, in turn,
(RSV) as the major cause of acute lower respiratory tractactivates a ribonuclease, RNAase L, which degrades vi-
diseases in infants as well as being responsible for up-ral mRNAs (Lengyel, 1987). This pathway has been
per respiratory tract infections in people of all ages (Cha-shown to be operative for the inhibition of picornaviruses,
nock and MacIntosh, 1990). Of the four serotypes of HPIV,such as encephalomyocarditis virus (EMC) and mengo
type 3 (HPIV-3) appears to be the most virulent and ac-virus (Chebath et al., 1987; Rysiecki et al., 1989; Coccia
counts for 60–70% of primary HPIV infection during theet al., 1990). (b) dsRNA-activated protein kinase R (PKR)
first 30 months of life (Glezen et al., 1984). Although intra-pathway; the overall effect of the activation of PKR is to
nasally administered IFNs have been evaluated clinicallyphosphorylate the eukaryotic translation initiation factor
for the prevention and treatment of viral respiratory infec-(eIF-2) whereby the protein synthesis is inhibited re-
tion (Hayden, 1988), a systematic and detailed study ofsulting in the impairment of viral replication (Mathews
the molecular basis of the inhibition of HPIV-3 by IFN isand Shenk, 1991). Human PKR has been cloned recently,
lacking (Cantell, 1995). In this report, we have investi-and constitutive expression of this cDNA in murine 3T3
gated the effect of IFN-a on the replication of HPIV-3 incells has been shown to confer a partial resistance to
cultured human lung carcinoma cells (A549), which is
highly permissive to HPIV-3 replication, and in human1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (216) 444-0512. Internet: banerja@cesmtp.ccf.org. brain glioblastoma cells (U87), which constitutively pro-
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duces MxA (U87-MxA) in which the measles virus repli- were collected and the virus yields were quantitated by
plaque assay as described above.cation has been shown to be restricted (Schneider-
Schaulies et al., 1994). Our results demonstrate that IFN-
Analysis of initial events in the HPIV-3 life cyclea significantly inhibits HPIV-3 replication in both A549
and U87 cells and mediates the inhibitory effect at the
[35S]Methionine-labeled HPIV-3 was prepared as de-
primary transcription of viral mRNAs. In contrast, expres-
scribed previously (Wechsler et al., 1985) and used to
sion of MxA in U87 cells conferred resistance to HPIV-3
analyze the adsorption and internalization of the virus in
infection at a post primary transcription step, suggesting
A549 cells as described in detail for VSV studies (Belkow-
that, besides MxA, other IFN-inducible protein(s) is in-
ski and Sen, 1987). Briefly, adsorption was assayed by
volved in the anti-HPIV-3 activity of IFN.
infecting monolayer A549 cells with 35S-HPIV-3 at an
m.o.i. of 5. To determine the effect of IFN-a on HPIV-3
MATERIALS AND METHODS adsorption to host cells, an equal number of IFN-treated
and untreated A549 cells were infected. After 1 hr ofCells, plasmids, viruses, IFNs, and antibodies
adsorption at 377 the monolayer was washed three times
Human lung carcinoma cells (A549, ATCC, CCL 185) with 10 mM HEPES (N-2-hydroxyethyl-peperazine-N-2-
and monkey kidney cells (CV-1, CCL 70, ATCC) were ethanesulfonic acid, pH 7.2)–150 mM NaCl (HEPES-sa-
obtained from American Type Culture Collection. A549 line) and lysed in HEPES-saline containing 0.5% sodium
cells were maintained in minimal essential medium con- dodecyl sulfate (SDS). The radioactivity in each lysate
taining 10% fetal calf serum. CV-1 cells were maintained was determined in a liquid scintillation counter.
in Dulbecco modified minimal essential medium con- Virus internalization was determined by infection of
taining 10% fetal calf serum. Stably MxA-transfected hu- the labeled virions as described above. After removal
man glioblastoma cell line U87-MxA and vector- of the inoculum and washing with HEPES-saline, fresh
transfected cell line U87-CL4 were kindly provided by Dr. medium was added and the cells were further incubated
S. Schneider-Schaulies (Institute for Virology and Immu- at 377 for 1 hr. The monolayer was washed three times
nology, Wurzburg, Germany) (Schneider-Schaulies et al., with HEPES-saline after the medium was removed and
1994) and maintained in minimal essential medium con- any virus remaining on the cell surface was removed by
taining 10% fetal calf serum and G418 (500 mg/ml). All incubation with 0.25% trypsin–0.25% EDTA for 7 min at
tissue culture reagents and media were obtained from room temperature. Trypsinization was stopped by the
Gibco BRL. addition of HEPES-saline containing 10% serum. The
The plasmid APR-1-MxA (containing the entire coding cells were harvested by centrifugation and washed twice
sequence of human MxA cDNA) and the polyclonal anti- with HEPES-saline plus 10% serum. The pellet was then
MxA antibody were provided by Dr. S. Schneider-Schau- solubilized and the radioactivity was determined as de-
lies (Schneider-Schaulies et al., 1994). Human GAPDH scribed above.
cDNA was obtained from Clontech. Individual viral
cDNAs of HPIV-3 (NP, P, HN, M, and F) were provided Northern blot analyses of HPIV-3-specific RNAs
by Dr. Mark Galinski.
For analysis of HPIV-3 RNAs, total cellular RNA wasStocks of HPIV-3 were prepared from and quantitated in
prepared from HPIV-3-infected cells. To analyze primaryCV-1 cells. Human IFN-a was obtained from Sigma Co.
transcripts of HPIV-3, during infection, the incubation was
carried out in the presence of 100 mM anisomycin inMeasurement of infectious virus yield
A549 cells and in the presence of 20 mg/ml cyclohexi-
mide (CHX) in U87 cells to inhibit protein synthesis asThe effect of IFN-a on infectious HPIV-3 yield was
measured in confluent monolayers of A549 cells in T150 detailed in the figure legends.
Total cellular RNA was isolated by a single-stepflasks. For dose-dependence study, the cells were
treated with the indicated doses of IFN-a for 24 hr and method described by Chomczynski and Sacchi (1987)
and indicated amounts of RNA sample were denaturedthen infected with HPIV-3 at indicated multiplicities of
infection (m.o.i.). For kinetics study, A549 cells were in- and electrophoresed in 1.2% agarose gels in the pres-
ence of 2.2 M formaldehyde. After electrophoresis thefected with HPIV-3 and were treated with IFN-a at a
concentration of 1000 U/ml at indicated time points post- RNA transferred to a Genescreen hybridization transfer
membrane (DuPont) by capillary method and fixed withinfection. The supernatants were collected at 40 hr post-
infection and the virus yields were quantitated by plaque UV light in a cross-linking oven (Strategene). HPIV-3
cDNA probes and, as the internal control, human GAPDHassay on CV-1 cells (De et al., 1995).
Similarly, the effect of MxA on infectious HPIV-3 yield cDNA (Clontech) were used for hybridization. All probes
were labeled with [a-32P]dCTP (DuPont) by using a ran-was measured in U87-MxA cells in T150 flasks. U87-CL4
served as control. Both cells were infected with HPIV-3 dom-primed DNA labeling kit (Boehringer Mannheim,
Germany) according to the manufacturer’s protocol. Pre-at indicated m.o.i. At 20 hr postinfection, the supernatants
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hybridizations and hybridizations were performed at 427
in a solution containing 50% formamide, 51 Denhardt’s
solution, 0.5% SDS, and 61 SSC. Filters were washed in
21 SSC plus 0.1% SDS twice for 30 min at 427 and then
0.11 SSC plus 0.5% SDS at 557 for 30 min. After autoradi-
ography, the individual bands were quantified using a
PhosphorImager (Molecular Dynamics).
Western blot analysis of MxA protein induced by IFN-
a in A549 and U87 cells
Both A549 and U87 cells were induced with IFN-a (200
U/ml) for indicated periods of time. Cells were harvested
and the cytoplasmic proteins were prepared. Twenty mi-
crograms of protein samples was resolved on a 12%
SDS–polyacrylamide gel and processed for Western blot
analyses using polyclonal anti-MxA antibody. Bacterially
expressed Histidine-tagged MxA protein (HisMxA) was
used as the positive control. The His-MxA was expressed
in pET-3a by PCR cloning method using APR-1-MxA plas-
mid as the template for amplification of MxA cDNA and
purified through a nickel affinity column (Barik and Ban-
erjee, 1991; Das et al., 1996). Similarly, the constitutive
expression of MxA in U87-MxA cells was analyzed by
Western blot as described above.
RESULTS
Effects of IFN-a on HPIV-3 production in A549 cells
As shown in Fig. 1, IFN-a-treated A549 cells are quite
refractory to HPIV-3 replication. In cells infected with FIG. 1. Anti-HPIV-3 activity of IFN-a in human lung carcinoma cells
HPIV-3 at an m.o.i. of 10, treatment with as low as 10 U/ (A549). (A) Concentration dependence of IFN-a-induced antiviral activ-
ity against HPIV-3 in A549 cells. Monolayer of A549 cells was treatedml IFN-a reduced the HPIV-3 production by more than
with various concentrations of IFN-a for 24 hr and then challenged10-fold (Fig. 1A). Increase of IFN concentration to 1000
with HPIV-3 (m.o.i. of 10) for another 40 hr. Virus yield was determinedU/ml led to more than 200-fold reduction in infective virus
by plaque assay as described under Materials and Methods. (B) Kinet-
yield in those cells. To study whether the inhibition of ics of induction of the antiviral state against HPIV-3 in A549 cells treated
HPIV-3 replication by IFN was at the early or late stage with IFN-a. A549 cells were challenged with HPIV-3 (m.o.i. of 10) fol-
lowed by treatment with saturating concentration (1000 U/ml) of IFN-of HPIV-3 infection, the kinetics of induction of antiviral
a at various periods of time postinfection. The virus yield at 40 hreffect in these cells were examined (Fig. 1B). Treatment
postinfection were then determined by plaque assay as described un-of A549 cells with 1000 U/ml IFN-a at the time of HPIV-
der Materials and Methods.
3 infection inhibited virus production by more than 90%.
However, the same concentration of IFN-a virtually lost
its ability to protect the cells from virus infection when HPIV-3, the effects of IFN on the attachment and pene-
added at 4 hr postinfection. These results suggest that tration of the virus to A549 cells were measured, as
early events of virus life cycle, such as adsorption, pene- detailed under Materials and Methods. The attach-
tration, and/or primary transcription, might be the main ment and penetration of HPIV-3 in IFNa-treated A549
target of IFN-a. cells occurred at 84 { 14% and 96 { 5%, respectively,
as compared to the control, suggesting that its inhibi-
Effects of IFN-a on entry of HPIV-3 to A549 cells tory effect is directed at a step(s) following attachment
and penetration of the virus.To determine the precise step(s) in the virus life
cycle at which IFN exerts its inhibitory effects, a sys-
Inhibition of HPIV-3-specific RNA synthesis by IFN-a
tematic analysis of events in the HPIV-3 life cycle was
in A549 cells
carried out. Since the kinetic data suggested that the
early events of virus life cycle was the main target of The effect of IFN on the steady-state levels of HPIV-
3-specific RNAs was then investigated in A549 cellsIFN-a, we first studied the effect of IFN on the entry of
HPIV-3 into these cells. Using [35S]methionine-labeled by Northern blot analyses. Total RNA was extracted
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FIG. 2. Effects of IFN-a on HPIV-3-specific RNA synthesis in A549 cells. Cells were treated with IFN-a at 200 U/ml for 24 hr prior to challenge
with HPIV-3 at an m.o.i. of 5. Total cellular RNA was extracted at 18 hr postinfection, and 5 mg of each RNA sample was applied for Northern blot
analysis with individual viral cDNAs F, HN, M, NP, and P. GAPDH cDNA was used as a control. In each panel, lane 1 contains RNA from the cells
without HPIV-3 infection. Lane 2 contains RNA from the cells infected with HPIV-3 in the absence of IFN-a. Lane 3 contains RNA from the cells
infected with HPIV-3 in the presence of IFN-a. Individual mRNAs as well as read-through products were marked on the left side of each panel.
v-RNA represents the viral genomic RNA.
from HPIV-3-infected cells at 18 hr postinfection and IFN-inducible protein(s) act at the primary transcrip-
tion step of HPIV-3 replication.5 mg of RNA from each sample was used for hybridiza-
tion with individual radiolabeled HPIV-3 cDNA probes,
while GAPDH cDNA was used as the internal control. Induction of MxA protein in A549 cells by IFN-a
The steady-state levels of HPIV-3-specific RNAs,
Since IFN-inducible protein, MxA (Horisberger, 1992)which include mRNAs encoding NP, P, M, F, and HN
has been shown to inhibit replication of several RNA(Banerjee et al., 1991), read-through products (P-M, P-
viruses (Pavlovic et al., 1990; Schnorr et al., 1993) andM-F, M-F), and full-length viral genomic RNA, were
more specifically at the primary transcription step of an-all inhibited more than 90% by IFN-treatment (Fig. 2).
other negative strand RNA virus, VSV, we wanted to studyThese results clearly demonstrate that inhibitory effect
whether MxA is indeed induced in A549 cells and itsof IFN-a is directed toward the synthesis of total HPIV-
role, if any, in HPIV-3 replication. As shown in Fig. 4, by3-specific RNAs.
Northern blot analysis (Fig. 4A), the MxA RNA, or byThe observed inhibition of viral RNA accumulation
Western blot analysis (Fig. 4C), the MxA protein was
may be accounted due to the inhibition of primary tran-
readily detectable following IFN treatment of A549 cells.
scription or due to inhibition of secondary transcrip-
In the absence of IFN-a, no synthesis of RNA and protein
tion (RNA replication) resulting from decreased viral
was detected. MxA-RNA appeared at 4 hr following IFN
protein synthesis. To determine the site of action of
induction and its synthesis increased and plateaued at
IFN among these two RNA synthetic steps, we main-
12 hr, suggesting a similar kinetics of appearance of
tained the cells infected with HPIV-3 for 12 hr in me-
MxA protein in these cells. It should be noted that the
dium containing 100 mM anisomycin, a potent inhibitor
delay in detecting MxA protein by Western blot was pos-
of protein synthesis that would restrict virus at the sibly due to less sensitivity of the anti-MxA antibody in
primary transcription step. As shown in Fig. 3, IFN-a the Western blot. Nevertheless, these results indicate
had a pronounced inhibitory effect on the accumula- that IFN-a was capable of inducing MxA protein rapidly
tion of primary transcripts of HPIV-3 as well as read- in the A549 cells, and the synthesized protein remained
through RNA products in HPIV-3-infected A549 cells. stable for at least 24 hr.
These data indicate that the primary transcription of
HPIV-3 is the main target of IFN-a. The level of the Resistance to HPIV-3 infection in U87-MxA cells
full-length genomic RNA contributed by the input virus
remained relatively unchanged in IFN-treated cells, The results in Fig. 4 suggested that MxA protein could
indicating that the inhibition of primary transcription be one of the IFN-inducible proteins that could potentially
by IFN was not due to the degradation of the genomic inhibit HPIV-3 replication. In order to investigate whether
RNA and was consistent with the finding that IFN-a MxA protein indeed plays a role in inhibiting HPIV-3 repli-
does not block the entry of HPIV-3 in these cells. Thus, cation, we used a stably transfected human brain gli-
oblastoma cell line, U87-MxA, in which the growth offrom the above results we conclude that the putative
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FIG. 3. Effects of IFN-a on the accumulation of HPIV-3 primary transcripts in A549 cells. Cells were treated with IFN-a at indicated concentrations
for 24 hr prior to challenge with HPIV-3 at an m.o.i. of 5 in the presence of 100 mM Anisomycin. Total RNA was extracted at 12 hr postinfection
and 25 mg of each RNA sample was applied for Northern blot analysis as described in the legend of Fig. 2. In each panel, lane 1 contains RNA
from the cells without HPIV-3 infection. Lane 2 represents RNA from the cells infected with HPIV-3 in the absence of IFN-a. Lanes 3 and 4 represent
RNA from the cells infected with HPIV-3 in the presence of IFN-a at 200 and 500 U/ml, respectively. Individual mRNAs as well as read-through
products were marked on the left side of each panel. v-RNA represents the viral genomic RNA.
measles virus has been shown to be restricted (Schnei- whereas at 1 m.o.i., 50- to 100-fold reduction of the virus
yield occurred. When the m.o.i. was increased to 10, ander-Schaulies et al., 1994). These cells were found to
express high levels of MxA in a constitutive manner as inhibition of only 20-fold was seen. The less pronounced
inhibition of HPIV-3 replication in U87-MxA cells at higherdetected by Western blot analyses (data not shown).
First, we compared the virus yield in U87-MxA cells with m.o.i. indicates that the resistance conferred by MxA can
be overcome by a high dose of replicating virus, an ob-control U87-CL4 cells infected with various dosages of
HPIV-3. As shown in Fig. 5, the virus titers from U-87- servation which is very similar to measles virus infection
in these cells (Schneider-Schaulies et al., 1994).MxA cells were appreciably reduced and this reduction
was dependent on the m.o.i. of virus used. When these Next, when the effect of MxA on the cytopathic effect
of HPIV-3 was studied, an expected difference was ob-cells were infected with HPIV-3 at 0.1 m.o.i., several hun-
dred-fold reduction in the virus yield was observed, served between MxA-producing cells and the control
ones (Fig. 6). At 20 hr postinfection (m.o.i. of 0.1), a wide-
spread cytopathic effect with characteristic syncytia for-
mation was seen in the non-MxA-producing cells U87-
FIG. 4. Induction of MxA mRNA and protein by IFN-a in A549 cells.
Cells were treated with IFN-a at 200 U/ml for various periods of time
as indicated. Total RNA and cytoplasmic protein were extracted. To
detect MxA mRNA, 5 mg of total RNA was electrophoresed on a 1.2%
agarose-formaldehyde gel followed by Northern blot with random-la-
beled MxA (A) or GAPDH (B) cDNA probes as described in the text. FIG. 5. Inhibition of HPIV-3 replication in U87-MxA cells. MxA-
transfected human glioblastoma cell line U87-MxA (¿) or control cellTo detect mXa protein, 20 mg protein was electrophoresed on a 12%
SDS–polyacrylamide gel followed by Western blot with anti-MxA poly- line U87-CL4 (…) was infected with HPIV-3 at various m.o.i. for 24 hr.
The virus yield was determined by plaque assay as described underclonal antibody (C) as described under Materials and Methods. MxA,
bacterially expressed His-MxA protein. Materials and Methods.
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induction. By Western blot analyses, we found that MxA
could be induced to a large extent in U87-CL4 cells (data
not shown) similar to that observed in A549 cells (Fig.
4). Moreover, in both cell lines, the synthesis of MxA
protein could be observed at 8 hr postinduction and re-
mained at a high level even after 24 hr, indicating that
this protein is quite stable in both cell lines.
We then tested the effect of IFN-a on the accumulation
of total HPIV-3-specific RNAs and primary transcripts in
U87-CL4 cells (Fig. 8) similar to that carried out in A549
cells (Figs. 2 and 3). The steady-state levels of both NP
and P mRNAs were reduced in IFN-treated U87-CL4 cells
by more than 95% (Fig. 8A) and the primary transcripts
of both NP and P were reduced by 50–75% (Fig. 8B).
FIG. 6. HPIV-3 infection and cytopathic effect in U87-MxA cells. U87- These results indicate that an IFN-induced protein(s), in
MxA cells or the control U87-CL4 cells were infected with HPIV-3 at addition to MxA, is involved in inhibiting HPIV-3 primary
an m.o.i. of 1 for 24 hr (bottom panels). The HPIV-3-specific cytopathic transcription.
effect is evident by rounding of the cells and formation of large syncytia.
Top panels are uninfected U87-CL4 cells and U87-MxA cells (from left
to right), respectively.
CL4 (Fig. 6, bottom left panel). In contrast, the cytopathic
effect in U87-MxA cells was much less pronounced (Fig.
6, bottom right panel). Thus, it seems that MxA-producing
cells conferred significant resistance to HPIV-3 infection.
HPIV-3-specific RNA synthesis in U87-MxA cells
The accumulation of HPIV-3-specific RNAs in U87-MxA
and in control cells was analyzed 12 hr postinfection at
an m.o.i. of 5 by Northern blot analysis using NP and P
cDNA probes (Fig. 7A). Similar to that observed for IFN-
a-treated A549 cells (Fig. 2), there was a significant re-
duction in the steady-state levels of both NP and P
mRNAs (80 and 70%, respectively). In contrast, the consti-
tutive expression of MxA did not have significant effect
on the primary transcripts of HPIV-3 when U87-MxA cells
were treated with CHX (Fig. 7B). The vRNA appeared in
a diffused band in these cell lines, and the levels in
control and MxA producing cells were confirmed to be
identical by phosphorimager scanning (data not shown).
This observation strongly suggests that MxA is acting at
FIG. 7. The effect of MxA protein on HPIV-3-specific RNA synthesis.
a post primary transcription step of the virus’s life cycle. (A) Restricted total viral RNA synthesis in HPIV-3 infected U87-MxA
cells. Both U87-CL4 and U87-MxA cells were challenged with HPIV-3
at an m.o.i. of 5. At 12 hr postinfection, total RNA was extracted and 5The effect of IFN-a on HPIV-3-infected U87-CL4 cells
mg RNA of each sample was applied for Northern blot analysis as
described in Fig. 2. In each panel, lane 1 represents RNA from theThe different effects caused by IFN-a on A549 (Fig. 3)
cells without viral infection, lane 2 and 3 represent the RNA from U87-and MxA producing U87-MxA cells (Fig. 7) on HPIV-3
CL4 and U87-MxA cells with HPIV-3 infection, respectively. Individualprimary transcription could be due to the difference in
viral mRNAs as well as read-through products were marked on the left
cell lines used. For example, the A549 cells are of human side of each panel. (B) No inhibition of viral primary transcription in
lung carcinoma origin, whereas U87-MxA cells are de- U87-MxA cells. Both U87-CL4 and U87-MxA cells were challenged with
HPIV-3 at an m.o.i. of 5 in the presence of CHX (20 mg/ml). At 8 hrrived from brain. Thus, MxA could target at a step in the
postinfection, total RNA was extracted and 25 mg RNA of each samplevirus life cycle differently in these cell lines. To address
was applied for Northern blot analysis as described in Fig. 2. In eachsuch a possibility, we studied the effect of IFN on HPIV-
panel, lane 1 represents RNA from the cells without viral infection, and
3 growth in U87-CL4 cells similar to that carried out in lanes 2 and 3 represent RNA from U87-CL4 and U87-MxA cells with
A549 cells. First, we studied the induction of MxA by IFN- HPIV-3 infection, respectively. Individual viral mRNAs as well as read-
through products were marked on the left side of each panel.a in U87-CL4 cells and compared the kinetics of this
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sis inhibitor, anisomycin (Fig. 3). Since IFN virtually had
no effect on adsorption and penetration of HPIV-3 into
A549 cells, this observed reduction of viral primary tran-
script accumulation could be due to a direct inhibition
of viral polymerase activity. In this respect, the action
of IFN-a against HPIV-3 is similar to that observed for
VSV where IFN does not have any effect on virus ad-
sorption and penetration, and IFN clearly inhibits virus
replication at the primary transcription step (Marcus
and Sekellik, 1978; Masters and Samuel, 1983; Belkow-
ski and Sen, 1987). Recently, Staeheli’s group has pro-
vided strong evidence that IFN-inducible protein MxA,
a GTPase, inhibits VSV replication at the primary tran-
scription step both in vitro and in vivo (Staeheli and
Pavlovic, 1991; Schwemmle et al., 1995), suggesting
that MxA has a role in the inhibition of VSV transcrip-
tion. These observations prompted us to look for the
effect of MxA in HPIV-3 replication and study whether
the IFN-inducible protein(s) that inhibits HPIV-3 primary
transcription is the MxA protein or whether other in-
duced proteins are involved in this inhibitory process.
It was apparent from our studies that A549 cells in-
duced MxA in amounts easily detectable by Western
blot analysis (Fig. 4), suggesting that MxA may be in-
volved in inhibiting HPIV-3 replication. To study the ef-
FIG. 8. Inhibition of HPIV-3-specific RNA synthesis by IFN-a in U87 fect of MxA in HPIV-3 replication, we used a human
cells. (A) Inhibition of total viral RNA synthesis in U87 cells by IFN-a. brain cell line constitutively expressing MxA (U87-MxA)
Cells were treated with saturated amount of IFN-a (200 U/ml) for 20
(Schneider-Schaulies et al., 1994). HPIV-3 replicationhr and followed by challenge with HPIV-3 at an m.o.i. of 5. At 12 hr
was significantly restricted in these cell lines (Fig. 5).postinfection, total RNA was extracted and 5 mg RNA of each sample
Subsequent analyses indicated that the action of MxAwas applied for Northern blot analysis as described in Fig. 2. In each
panel, lane 1 represents RNA from the cells with viral infection, lane was not directed toward the primary transcription step
2 represents RNA from the cells infected with HPIV-3 in the absence of HPIV-3 replication. These results suggest either MxA
of IFN-a, lane 3 represents RNA from the cells infected with HPIV-3 in
acts at some step(s) downstream in the RNA syntheticthe presence of IFN-a. Individual viral mRNAs as well as read-through
process (Fig. 7) or must associate with another IFN-products were marked on the left side of each panel. (B) Inhibition of
inducible protein to be able to act at the primary tran-HPIV-3 primary transcription by IFN-a in U-87 cells. Cells were treated
with saturated amount of IFN-a (200 U/ml) for 20 hr followed by chal- scription step. The latter possibility seems to have
lenge with HPIV-3 at an m.o.i. of 5 in the presence of CHX (20 mg/ml). some merit since the parental cell line (U87-CL4), which
At 8 hr postinfection, total RNA was extracted and 25 mg RNA of each
induced MxA, albeit at a low level after IFN-treatment,sample was applied for Northern blot analysis as described in the
restricted HPIV-3 at the primary transcription step oflegend of Fig. 2. In each panel, lane 1 represents RNA from the cells
virus replication (Fig. 8). These results taken togetherwithout viral infection, lane 2 represents RNA from the cells infected
with HPIV-3 in the absence of IFN-a, lane 3 represents RNA from the suggest that other IFN-inducible proteins, either inde-
cells infected with HPIV-3 in the presence of IFN-a. Individual viral pendently or in association with MxA, are involved in
mRNAs as well as read-through products were marked on the left side
inhibiting primary transcription. It is interesting to noteof each panel.
that involvement of a putative IFN-inducible RNase dis-
tinct from RNase L, in degrading primary transcripts of
DISCUSSION VSV, has been shown by Kumar et al. (1988) as a possi-
ble mechanism of IFN-mediated inhibition of VSV. How-In this communication we have shown that IFN-a
significantly inhibits replication of HPIV-3 in human ever, MxA has been shown to inhibit primary transcrip-
tion of VSV in mouse 3T3 cells stably expressing MxAlung carcinoma cells (A549) making IFN a potent antivi-
ral agent for HPIV-3 in addition to many other RNA (Staeheli and Pavlovic, 1991). Thus, it appears that host
cell may play an important role in regulating the modeviruses (Muller et al., 1994). The presumptive IFN-in-
ducible protein(s) appears to exert its antiviral effect at of action of MxA. This contention is further strength-
ened by the observation that measles virus is restrictedthe primary transcription step of HPIV-3 replication
since IFN-treated A549 cells infected with HPIV-3 accu- in different cell lines stably expressing MxA at different
pathways in the virus’s replicative cycle (Schnorr et al.,mulated significantly less virus-specific RNAs com-
pared to control cells in the presence of protein synthe- 1993; Schneider-Schaulies et al., 1994). Thus, it seems
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and characterization of Rhabdovirus polymerase. Methods Enzymol.,that the targets of IFN-inducible protein(s) in the virus’s
in press.life cycle are multifarious and depending on the host
De, B. P., Gupta, S., Gupta, S., and Banerjee, A. K. (1995). Cellular
environment and the virus used, the inducible proteins protein kinase C z regulates human parainfluenza virus type 3 repli-
may change the target site(s) to inhibit virus replication. cation. Proc. Natl. Acad. Sci. USA 92, 5204–5208.
Glezen, W. P., Frank, A. L., Taber, L. H., and Kasel, J. A. (1984). Parainflu-Finally, our studies demonstrated that IFN-a is a po-
enza virus type 3: Seasonality and risk of infection and reinfectiontent anti HPIV-3 agent and, in addition to MxA, other
in young children. J. Infect. Dis. 150, 851–857.IFN-inducible proteins are involved in inhibiting HPIV-3
Hayden, F. G. (1988). Interanasal interferons for control of respiratory
replication. Whether MxA associates with other cellular viral infections. ‘‘Clinical Aspects of Interferons’’ (M. Revel, Ed.), pp.
protein(s) (Horisberger, 1992; Obar et al., 1990) to mani- 3–16. Kluwer Academic, Boston.
Horisberger, M. A., McMaster, G. K., Zeller, H., Wathelet, M. G., Dellis,fest its activity is currently unknown. The fact that IFN-
J., and Content, J. (1990). Cloning and sequence analyses of cDNAsa exerts significant anti-HPIV-3 action in A549 cells
for interferon- and virus-induced human Mx proteins reveal that theysupports the contention that it can be used as a thera-
contain putative guanine nucleotide-binding sites: Functional study
peutic agent for respiratory ailment caused by HPIV-3 of the corresponding gene promoter. J. Virol. 64, 1171–1181.
infection (Hayden, 1988). Studies are in progress to Horisberger, M. A. (1992). Interferon-induced human protein MxA is a
GTPase which binds transiently to cellular proteins. J. Virol. 66, 4705–understand, in detail, the mechanism of action of both
4709.IFN and MxA and characterization of other IFN-induc-
Kerr, I. M., and Stark, G. R. (1992). The antiviral effects of the interferonsible proteins involved in the inhibition of HPIV-3 repli-
and their inhibition. J. IFN Res. 12, 237–240.
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